Vortex enhanced liquid chromatography for HbA1c monitoring based diabetes management in a globalized setting

VortexLC aims to develop a cost-effective point-of-care device for accurate HbA1c quantification in diabetes patients, utilizing advanced polymer columns for improved analysis and mass manufacturing.

Subsidie
€ 3.014.375
2022

Projectdetails

Introduction

Diabetes is one of the main health risks today with near pandemic dimensions, causing blindness, kidney failures, stroke, and heart attack. This condition gives rise to very high health care costs (25% in the US) and reduces the quality of life for around 500 million people worldwide.

Importance of HbA1c Measurement

The level of hemoglobin A1c (HbA1c) is used to assess long-term glycemic control and is the best predictor for the risk of developing chronic complications of diabetes. It also aids in the appropriate follow-up of patients.

Limitations of Current Methods

The golden standard is an expert laboratory HPLC method focusing on HbA1c quantification. However, this method has limitations when other relevant hemoglobin variants need to be detected. For approximately 7% of the world’s population who are carriers of such hemoglobin variants, current methods lead to:

  • Under-estimation of the HbA1c fraction
  • Over-estimation of the HbA1c fraction
  • Non-estimation of the HbA1c fraction

VortexLC Solution

VortexLC aims to improve the quality of the analysis to provide an instant full picture of the health status of diabetes patients. It will also produce a cost-effective point-of-care device.

Advantages of Vortex Flows

The use of vortex flows renders the approach compatible with mass manufacturing of plastic pillar array columns. These columns are:

  1. Much cheaper than commonly used packed bed columns
  2. Capable of achieving higher separation performances

Manufacturing Process

The polymer columns will be fabricated using several advanced techniques:

  • UV-nanoimprint lithography
  • Plasma technology to make them porous and add a chromatographic coating
  • Lamination to close the column

All these processes can be scaled to roll-to-roll industrial manufacturing.

Instrumentation and Testing

The columns will be embedded in an instrument that allows for:

  • Integrated sample preparation
  • Miniaturized UV absorption and SERS detection

This setup will enable both quantification and identification of analytes.

Project Goals

In the project, a low footprint demonstrator of the novel system and columns will be built and tested with:

  1. First synthetic samples
  2. Next, human blood samples

The goal is to quantify HbA1c and its genetic variants.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.014.375
Totale projectbegroting€ 3.014.375

Tijdlijn

Startdatum1-3-2022
Einddatum28-2-2026
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • VRIJE UNIVERSITEIT BRUSSELpenvoerder
  • "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
  • JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
  • COATING PLASMA INNOVATION SAS

Land(en)

BelgiumGreeceAustriaFrance

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabetes

This project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications.

€ 3.885.462
EIC Pathfinder

In-vessel implantable smart sensing device for personalised medicine

The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.

€ 4.158.610

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

Column with AC-EOF Induced Vortices for HPLC

The project aims to enhance blood analysis efficiency by integrating vortex mixing in HPLC columns, enabling faster separations for improved diagnostics, including diabetes monitoring.

€ 150.000
EIC Accelerator

The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale

Developing a non-invasive glucose monitoring device to improve diabetes management and prevent onset for over 2 billion people through EIC blended finance support.

€ 2.500.000
ERC Proof of...

Metal-Organic-Framework Kinetic Array for Diabetes Detection

This project aims to develop a novel sensor using metal-organic frameworks to selectively detect volatile organic compounds in breath for non-invasive diabetes diagnosis.

€ 150.000
Mkb-innovati...

AFIDI

Het project ontwikkelt een betaalbare, minimaal invasieve CGM-sensor voor diabetespatiënten, die data veilig beheert en artsen toegang geeft, ter verbetering van zorg en vroegtijdige detectie van vaatlijden.

€ 344.962
Mkb-innovati...

TIER - phoTonics dIagnosis hEpatocellular caRcinoma

Dit project ontwikkelt een prototype voor de validatie van een panel van 4 HCC-biomarkers, gericht op het verbeteren van de vroege diagnose van hepatocellulair carcinoom bij levercirrose.

€ 197.979